Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

Mass vaccination with modified-live PRRSV vaccine has no significant production impact in stable herds

Mass vaccination with a modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine has no significant negative impact on production performance in PRRSV-stable breeding herds, indicate the results of a recent study.

Investigators analyzed reproductive performance in eight PRRSV-stable breeding herds vaccinated with one of three commercial modified-live PRRSV vaccines (Ingelvac PRRS® MLV, Ingelvac PRRS® ATP or Fostera® PRRS).  The herds were vaccinated quarterly for 2 years, totaling 64 herd mass vaccinations, and performance was evaluated based on five key performance indicators, each adjusted to per 1,000 sows:

  • Number of abortions per week
  • Weekly preweaning mortality
  • Weekly prenatal losses
  • Total pigs weaned per week
  • Wean-to-first-service intervals

The scientists then used statistical process-control (SPC) methods to measure changes in production indicators, reported Sam Baker, VetMB, Columbia University’s Institute of Comparative Medicine, and Daniel Linhares, DVM, PhD, Iowa State University (ISU), at the 2017 ISU James D. McKean Swine Disease Conference. SPC methods involve the use of graphs to study how variation in processes change over time.

The investigators said the median interquartile range — a measure of data distribution — was 0.0 to 4.8 for increased abortions, 0.0 to 0.2 for prenatal losses, 0.0 to 8.0 for preweaning mortality, 0.0 to 0.0 for total pigs weaned and 0.0 to 0.0 for wean-to-first-service intervals, according to the results of the study, which was funded by the American Association of Swine Veterinarians Foundation.

They said the study will provide information to feed existing economic models that can help swine veterinarians make informed decisions about using modified-live PRRSV vaccines as a preventive tool.

They noted, however, that more research is needed to evaluate the first-time use of modified-live PRRSV vaccines in PRRSV-naïve farms to determine if it can minimize losses associated with outbreaks of wild-type PRRSV where the risk of introduction is high.

Ingelvac PRRS® is a registered trademark of Boehringer Ingelheim Vetmedica. Fostera® is a registered trademark of Zoetis Services LLC.

 


tags: ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.